Calculate your body mass index (BMI)

Weight

Feet

Inches

Your BMI

Back to list

Asthmatic Volunteers 240729


Study Dates: 23/11/19 - 31/3/20

Trial Number

240729

Group

●  Asthma
●  Non-Childbearing Females

Compensation

Up to: $4,820

Gender

Male, Female, Non-Smoker

Age

18-65 years

Additional Information

Part 2 of this study will recruit up to 78 non-smoking, male and female (of non-childbearing potential) patients with mild asthma between 18 and 65 years old.

Cohort 2a:

  • Admission: 23 November 2019
  • Discharge: 8 December 2019
  • Outpatient: 9 December 2019
  • Follow-up: 12 December 2019


Please call Recruitment on 01895 614 888 for upcoming screening dates.

Details

We are currently recruiting Mild Asthmatics who are using the Blue sulbutamol inhaler (Ventolin), only.

The study involves a stay of 15 nights in our unit with two follow up visits. Total duration of the study is 18 days.

Start dates are flexible so please call us to see if we can work around your calander.


The main purpose of the study is to see how safe the Study Drug is and how well it is tolerated after dosing.

The study will also investigate:

• How the Study Drug is taken up, metabolised (chemically broken down), distributed through the body and excreted, this is called the pharmacokinetics (PK) of the Study Drug.

• How the body is affected by the Study Drug, this is called the pharmacodynamics (PD) of the Study Drug.

• Try to understand why different people respond differently to the same drug through DNA testing (please refer to the separate informed consent form for genetic testing).The sponsor is developing the study drug as a treatment for asthma. Asthma is a chronic disease of the airways that makes breathing difficult. The study drug works by preventing the formation of certain proteins by the immune system, which cause inflammation (swelling), and so reducing the symptoms of asthma.


This is a first time in human study.